Lmr Partners LLP Ampio Pharmaceuticals, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $11,120 - $32,665	69,501 New	69,501 $12,000
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $177,679 - $225,516	-113,897 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.36 - $2.49 $154,899 - $283,603	113,897 New	113,897 $192,000
Q4 2019 Feb 14, 2020	SELL	$0.35 - $0.58 $10,862 - $18,000	-31,035 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.39 - $0.7 $12,103 - $21,724	31,035 New	31,035 $12,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.